Partial Mastectomy Methods for Breast Cancer
Trial Summary
Do I need to stop my current medications for the trial?
The trial protocol does not specify whether you need to stop taking your current medications. However, it mentions that patients may have received or may be receiving endocrine therapy, suggesting that some medications might be allowed.
What data supports the effectiveness of the treatment Partial Mastectomy Methods for Breast Cancer using Savi Scout® localization?
Research shows that the Savi Scout system is an accurate and reliable method for localizing and removing breast lesions, with acceptable rates of needing additional surgery to remove cancerous tissue. It overcomes many limitations of other localization methods, making it a promising option for breast cancer surgery.12345
What makes the partial mastectomy with Savi Scout® localization and selective shave margins treatment unique for breast cancer?
This treatment is unique because it uses the Savi Scout® system, which is a radar-based technology, to precisely locate the tumor before surgery, reducing the need for uncomfortable wire localization. Additionally, the use of selective shave margins helps ensure that no cancerous tissue is left behind, potentially lowering the risk of cancer recurrence.678910
What is the purpose of this trial?
This is a prospective study comparing partial mastectomy performed with routine cavity shave margins and Savi Scout® localization to partial mastectomy performed with selective margins and Savi Scout® localization. The primary objective is to determine the difference in positive margin rate between the two methods. The secondary objectives are to determine the differences in the rate of re-excision, volume of tissue extracted and Breast-Q® score between the two methods. It is hypothesized that the Savi Scout® will allow for decreased volume of tissue excised when compared to routine cavity shave margins without any difference in positive margin rate or rate of re-excision.
Research Team
Andrew Fenton, M.D.
Principal Investigator
Cleveland Clinic Akron General, Case Comprehensive Cancer Center
Eligibility Criteria
This trial is for women aged 18 or older with early-stage breast cancer (stage I-II) or stage 0 DCIS, diagnosed via core needle biopsy and suitable for breast-conserving therapy. Participants must be patients at Cleveland Clinic Akron General.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo partial mastectomy with Savi Scout® localization and either routine or selective cavity shave margins
Follow-up
Participants are monitored for safety and effectiveness after surgery, including completion of the Breast-Q® questionnaire
Treatment Details
Interventions
- Partial mastectomy with Savi Scout® localization and selective shave margins
- Partial mastectomy with Savi Scout® localization and shave margins
Partial mastectomy with Savi Scout® localization and selective shave margins is already approved in United States, European Union for the following indications:
- Breast cancer
- Partial mastectomy guidance
- Breast cancer
- Partial mastectomy guidance
Find a Clinic Near You
Who Is Running the Clinical Trial?
Case Comprehensive Cancer Center
Lead Sponsor
Cleveland Clinic Akron General
Lead Sponsor